C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2186034C Highly efficient production and isolation of viral particles
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
11/26/2002	CA2105984C Cloning and expression of renilla luciferase
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2087164C Target specific antibody-superantigen conjugates and their preparation
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/26/2002	CA2067901C Novel polypeptides with affinity to lipopolysaccharides and their uses
11/26/2002	CA2066913C Novel binding peptides
11/26/2002	CA2027075C Mutein of hst-1 and production therof
11/26/2002	CA2026703C Genetic manipulations with recombinant dna comprising sequences derived from rna virus
11/26/2002	CA1341401C Immunosuppressant factor derived from human glioblastoma cells
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002093161A1 Screening method
11/21/2002	WO2002092846A1 Method of monitoring a fermentation process
11/21/2002	WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	WO2002092840A2 Agents that regulate apoptosis
11/21/2002	WO2002092839A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/21/2002	WO2002092837A2 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
11/21/2002	WO2002092835A2 Isolated human g protein-coupled receptor
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092831A2 Method for identifying ligands for g protein coupled receptors
11/21/2002	WO2002092829A1 Process for producing peptide
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092823A1 Novel sequences and their use
11/21/2002	WO2002092818A2 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
11/21/2002	WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002	WO2002092814A2 Screening method for attenuating or virulence defective microbial cells
11/21/2002	WO2002092810A1 Peptides having cytotoxicity inhibitory activity and method of screening these peptides having cytotoxicity inhibitory activity
11/21/2002	WO2002092805A1 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tuberculosis
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092787A2 Human secreted proteins
11/21/2002	WO2002092785A2 Composition and methods relating to ovarian specific genes and proteins
11/21/2002	WO2002092784A2 POLYNUCLEOTIDES AND POLYPEPTIDES RELATING TO THE MODULATION OF SIRP α-CD47
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092765A2 Novel telomerase inhibitors and uses therefor
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092763A2 Intron associated with myotonic dystrophy type 2 and methods of use
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092761A2 Screening assays for agonists or antagonists of cd40 signaling
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002	WO2002092635A2 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
11/21/2002	WO2002092631A1 Kinetic assay
11/21/2002	WO2002092630A1 High density lipoprotein-reactive peptides
11/21/2002	WO2002092629A1 Polynucleotides and polypeptides linked to cancer and/or tumorigenesis
11/21/2002	WO2002092628A2 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
11/21/2002	WO2002092627A2 Use of casb 7439 for treatment and diagnosis of lung cancer
11/21/2002	WO2002092626A2 Cleavage and polyadenylation complex of precursor mrna
11/21/2002	WO2002092625A2 Moraxella(branhamella) catarrhalis antigens
11/21/2002	WO2002092624A2 G-protein coupled receptor
11/21/2002	WO2002092623A1 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
11/21/2002	WO2002092621A1 Isolated human secreted proteins nucleic acid molecules encoding human secreted proteins and uses thereof
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002092619A2 Modified growth hormone
11/21/2002	WO2002092147A2 Optimization of the molecular properties and formulation of proteins delivered by inhalation
11/21/2002	WO2002092134A1 Lentiviral vectors encoding clotting factors for gene therapy
11/21/2002	WO2002092131A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002	WO2002092122A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	WO2002092120A1 Structurally modified peptides and uses thereof
11/21/2002	WO2002092119A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002	WO2002092118A1 Global analysis of protein activities using proteome chips
11/21/2002	WO2002092117A1 Method and compositions for inhibiting thrombin-induced coagulation
11/21/2002	WO2002092055A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
11/21/2002	WO2002092020A2 Compositions and methods for modulating bone mineral deposition
11/21/2002	WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002	WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	WO2002092011A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002092001A2 Compositions and methods for the therapy and diagnosis of lung cancer
11/21/2002	WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002	WO2002091996A2 Methods for treating cancer
11/21/2002	WO2002091991A2 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use
11/21/2002	WO2002091820A1 Nonhuman model animal of oligodendrocyte development disability
11/21/2002	WO2002079756A9 Novel molecules of the multi-drug and toxin efflux (mate) protein family and uses thereof
11/21/2002	WO2002079447A9 Avian lysozyme promoter
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002072798A9 Fas ligand-expressing hematopoietic cells for transplantation
11/21/2002	WO2002070686A3 Cctra gene as a tool for the generation of a male progeny in the mediterranean fruitfly ceratitis capitata
11/21/2002	WO2002064750A3 Expression system for seed proteins
11/21/2002	WO2002059604A8 Diagnosis and treatment of multiple sclerosis
11/21/2002	WO2002057779A9 Cloning and expression of a new mcp receptor in glial cells
11/21/2002	WO2002057290A3 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/21/2002	WO2002055720A3 Materials and methods relating to protein aggregation in neurodegenerative disease
11/21/2002	WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002	WO2002052014A3 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells
11/21/2002	WO2002046402A3 Regulation of human patched-like protein
11/21/2002	WO2002036603A3 Nucleic acid sequence for a human beta tubulin
11/21/2002	WO2002018637A3 Diagnosis and treatment of prostate cancer
11/21/2002	WO2002014467A3 Cng2b: a putative human cyclic nucleotide-gated ion channel
11/21/2002	WO2002000926A3 Diagnosis of diseases associated with signal transduction
11/21/2002	WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002	WO2001094383A3 Mutated furin polypeptides having improved characteristics
11/21/2002	WO2001034646A9 Recombinant gelatins
11/21/2002	WO2001019844A9 Altered nucleotide sequence in cd40 ligand promotor
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	WO2001017559A9 Semaphorin modulation of immune cell migration
11/21/2002	US20020174454 Overexpression of ABI5 in plants to prevent precocious seed germination and to confer resistance to drought and high salt

1 ... 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 ... 2916